血红蛋白病市场:按测试类型、按适应症、按最终用户、按地区-规模、份额、展望、机会分析，2023-2030年

血红蛋白异常病是一组遗传性疾病，其中血红蛋白分子的产生和结构存在异常。 血红蛋白病是一个医学术语，指一组主要影响红细胞的遗传性血液疾病和疾病。 镰状细胞病 (SCD) 是一种血液疾病，当异常血红蛋白损害红细胞并使红细胞变形时就会发生这种疾病。 它大致分为由血红蛋白基因突变引起的结构性血红蛋白病和由正常血红蛋白分子变化引起的地中海贫血。 主要的结构血红蛋白变体是 HbS、HbE 和 HbC。 地中海贫血的主要类型是ALPHA-地中海贫血和BETA-地中海贫血。 一些导致血红蛋白异常的疾病也会影响血红蛋白的产生，因此这两种疾病可能会重迭。

一些血红蛋白异常不会引起病理或贫血，因此通常不被归类为血红蛋白病。 常见症状包括剧烈疼痛、呼吸短促、脾臟肿大以及儿童发育迟缓。 血红蛋白病是一组由红细胞中血红蛋白异常引起的疾病。

市场动态

为了扩大产品组合，市场主要参与者越来越多地采用合作伙伴关係等有机增长战略，预计这将在预测期内推动市场增长。 例如，2022 年 6 月，美国临床阶段基因编辑上市公司 Precision BioSciences 与製药公司诺华公司 (Novartis AG) 宣布建立合作伙伴关係，开发针对血液疾病的新型基因疗法。

本研究的主要特点

• 本报告对全球血红蛋白病市场进行了深入分析，提供了以 2022 年为基准年的预测期内（2023-2030 年）的市场规模和復合年增长率 (CAGR%)。
• 它揭示了各个细分市场的潜在收入机会，并概述了该市场有吸引力的投资主张矩阵。
• 它还提供了有关市场驱动因素、限制因素、机遇、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
• 根据以下参数对全球血红蛋白病市场主要参与者进行概况分析，包括公司亮点、产品组合、主要亮点、财务业绩和战略。
• 本研究涵盖的主要公司包括 Anamol Laboratories Pvt. Ltd., Bio-Rad Laboratories, Inc., PerkinElmer Inc., Zentech, Sebia, Sysmex Europe SE, Nanjing Poclight Biotechnology Co., Ltd, Abbott, Danaher, ReachBio LLC, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Nexcelom Bioscience LLC., NIHON KOHDEN CORPORATION, Siemens Healthcare GmbH, CRISPR Therapeutics.。
• 该报告的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
• 全球血红蛋白病市场报告面向该行业的各个利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和财务分析师。
• 利益相关者可以通过用于分析全球血红蛋白病市场的各种策略矩阵来促进决策。

内容

第 1 章目的和先决条件

• 调查目的
• 先决条件
• 缩写

第 2 章市场展望

• 报告摘要
  • 市场定义和范围
• 执行摘要
• 连贯的机会地图 (COM)

第 3 章市场动态、监管与趋势分析

• 市场动态
  • 促进因素
  • 制约因素
  • 市场机会
• 影响分析
• 主要亮点
• 产品发布
• 技术进步
• PEST分析
• 监管场景
• 併购

第 4 章全球血红蛋白病市场 - 冠状病毒 (COVID-19) 大流行的影响

• 经济影响
• 关于 COVID-19 的流行病学
• 对供需的影响

第 5 章全球血红蛋白病市场，按测试类型，2017-2030 年

• 常规红细胞 (RBC) 计数
• 基因检测
• 高效液相色谱法检测血红蛋白
• 血红蛋白等电聚焦 (Hb IEF)
• 血红蛋白电泳 (Hb ELP)
• 血红蛋白溶解度测试

第 6 章全球血红蛋白病市场（按适应症），2017-2030 年

• 镰状细胞病
• Beta地中海贫血
• 阿尔法地中海贫血

第 7 章全球血红蛋白病市场，按最终用户划分，2017-2030 年

• 医院
• 诊断实验室
• 医务室

第 8 章全球血红蛋白病市场:地区，2017-2030

• 北美
• 美国
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地区
• 欧洲
• 英国
• 德国
• 意大利
• 法国
• 西班牙
• 俄罗斯
• 欧洲其他地区
• 亚太地区
• 中国
• 印度
• 日本
• 东盟
• 澳大利亚
• 韩国
• 亚太地区其他地区
• 中东
• 海湾合作委员会
• 以色列
• 其他中东地区
• 非洲
• 北非
• 中非
• 南非

第 9 章竞争格局

• Anamol Laboratories Pvt. Ltd.
• Bio-Rad Laboratories, Inc.
• PerkinElmer Inc.
• Zentech
• Sebia
• Sysmex Europe SE
• Nanjing Poclight Biotechnology Co., Ltd
• Abbott
• Danaher
• ReachBio LLC
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Nexcelom Bioscience LLC.
• NIHON KOHDEN CORPORATION
• Siemens Healthcare GmbH
• CRISPR Therapeutics

第 10 章

• 调查方法
• 关于出版商

Hemoglobinopathy are a group of disorders that are inherited, in which there is abnormal production or structure of the hemoglobin molecule. Hemoglobinopathy is the medical term for a group of inherited blood disorders and diseases that primarily affect red blood cells. Sickle cell disease (SCD) is one such blood disorder caused by the abnormal hemoglobin that damages and deforms red blood cells. There are two main groups, which are abnormal structural hemoglobin variants caused by mutations in the hemoglobin genes, and the thalassemias, which are caused by an alteration in normal hemoglobin molecules. The main structural hemoglobin variants are HbS, HbE and HbC. The main types of thalassemia are alpha-thalassemia and beta thalassemia. The two conditions may overlap because some conditions, which cause abnormalities in hemoglobin proteins also affect their production.

Some hemoglobin variants do not cause pathology or anemia, and thus are often not classed as hemoglobinopathies. Common symptoms of the condition include, severe pain, shortness of breath, enlarged spleen, and growth problems in children. It can be any group of disorders caused by the presence of variant hemoglobin in the red blood cells.

Market Dynamics

Increasing adoption of organic growth strategies, such as partnerships by key players in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in June 2022, Precision BioSciences, a publicly traded American clinical stage gene editing company, and Novartis AG, a pharmaceutical corporation, announced that they have entered into a partnership to develop new gene therapy for blood disorders.

Key features of the study:

• This report provides in-depth analysis of the global hemoglobinopathy market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global hemoglobinopathy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study are Anamol Laboratories Pvt. Ltd., Bio-Rad Laboratories, Inc., PerkinElmer Inc., Zentech, Sebia, Sysmex Europe SE, Nanjing Poclight Biotechnology Co., Ltd, Abbott, Danaher, ReachBio LLC, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Nexcelom Bioscience LLC., NIHON KOHDEN CORPORATION, Siemens Healthcare GmbH, CRISPR Therapeutics.
• Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global hemoglobinopathy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hemoglobinopathy market

Detailed Segmentation:

• Global Hemoglobinopathy Market, By Test Type:
  • Routine Red Blood Cell (RBC) count
  • Genetic Testing
  • Hemoglobin by high performance liquid chromatography
  • Hemoglobin isoelectric focusing ( Hb IEF)
  • Hemoglobin electrophoresis (Hb ELP)
  • Hemoglobin solubility test
• Global Hemoglobinopathy Market, By Indication:
  • Sickle Cell Disease
  • Beta Thalassemia
  • Alpha Thalassemia
• Global Hemoglobinopathy Market, By End User:
  • Hospitals
  • Diagnostic Laboratories
  • Clinics
• Global Hemoglobinopathy Market, By Region:
  • North America
    • By Country:
  • U.S.
  • Canada
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Anamol Laboratories Pvt. Ltd.*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer Inc.
  • Zentech
  • Sebia
  • Sysmex Europe SE
  • Nanjing Poclight Biotechnology Co., Ltd
  • Abbott
  • Danaher
  • ReachBio LLC
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Nexcelom Bioscience LLC.
  • NIHON KOHDEN CORPORATION
  • Siemens Healthcare GmbH.
  • CRISPR Therapeutics

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Test Type
  • Market Snapshot, By Indication
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Key Highlights
• Product Launch
• Technological Advancements
• PEST Analysis
• Regulatory Scenario
• Mergers and Acquisitions

4. Global Hemoglobinopathy Market- Impact of Coronavirus (Covid-19) Pandemic

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Hemoglobinopathy Market, By Test Type, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Routine Red Blood Cell (RBC) count
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Genetic Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Hemoglobin by high performance liquid chromatography
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Hemoglobin isoelectric focusing ( Hb IEF)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Hemoglobin electrophoresis (Hb ELP)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Hemoglobin solubility test
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Hemoglobinopathy Market, By Indication, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Sickle Cell Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Beta Thalassemia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Alpha Thalassemia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Hemoglobinopathy Market, By End User, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segments Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Hemoglobinopathy Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Anamol Laboratories Pvt. Ltd.*
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Bio-Rad Laboratories, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• PerkinElmer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Zentech
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Sebia
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Sysmex Europe SE
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Nanjing Poclight Biotechnology Co., Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Danaher
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• ReachBio LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Nexcelom Bioscience LLC.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• NIHON KOHDEN CORPORATION
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Siemens Healthcare GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• CRISPR Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

10. Section

• Research Methodology
• About Us